Metraipolis › archive › dc_67986129a2bd
Patient-specific pharmacogenomics demonstrates xCT as predictive therapeutic target in colon cancer with possible implications in tumor connectivity — Europe PMC PMID:40988536
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40988536
- DOI
- 10.1002/1878-0261.70129
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T19:16:31.512Z
- SHA-256 of the archived text
0b51896a82f0df2e1d5422da8aeefd43351d1bb70a57b1cce03325a22ffe6b44- Stable URL of this page
https://metraipolis.com/documento/dc_67986129a2bd
How to cite
Patient-specific pharmacogenomics demonstrates xCT as predictive therapeutic target in colon cancer with possible implications in tumor connectivity — Europe PMC PMID:40988536 — Europe PMC (en), https://europepmc.org/article/MED/40988536 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_67986129a2bd (Metraipolis archive dc_67986129a2bd, sha256 0b51896a82f0df2e1d5422da8aeefd43351d1bb70a57b1cce03325a22ffe6b44)
BibTeX
@misc{dc67986129a2bd,
title = {Patient-specific pharmacogenomics demonstrates xCT as predictive therapeutic target in colon cancer with possible implications in tumor connectivity — Europe PMC PMID:40988536},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40988536},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_67986129a2bd; sha256 0b51896a82f0df2e1d5422da8aeefd43351d1bb70a57b1cce03325a22ffe6b44},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40988536. Agents can read the archived copy with the MCP tool read_document.